Tobacco Cessation Treatment Pathways for Patients With Cancer: 10 Years in the Making

Restricted access

Tobacco use is the most common cause of preventable morbidity and mortality in the United States; it accounts for one-third of all cancer deaths and is thought to account for half of preventable cancer deaths. This article describes the Tobacco Treatment Program at a major academic cancer center. Patients and employees may access these services in a number of ways. All current smokers and recent quitters are proactively contacted and invited to participate. Services provided are tailored to the motivational level of individual patients and their immediate medical needs. The treatment pathways we present are based on our experience from the last 10 years in treating more than 5,000 unique patients with around 60,000 patient visits. These pathways include behavioral counseling and pharmacotherapy, including first-line, second-line, and off-label medication use. This article describes the program with the goal of providing guidance and ideas to others who are developing treatment programs and providing treatment to tobacco users.

Correspondence: Maher Karam-Hage, MD, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Unit 1330, Houston, TX 77030. E-mail: maherkaram@mdanderson.org
  • 1.

    van MeijgaardJFieldingJE. Estimating benefits of past, current, and future reductions in smoking rates using a comprehensive model with competing causes of death. Prev Chronic Dis2012;9:E122.

    • Search Google Scholar
    • Export Citation
  • 2.

    FioreMCJaenCRBakerTB. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Available at: http://bphc.hrsa.gov/buckets/treatingtobacco.pdf. Accessed October 7 2016.

    • Search Google Scholar
    • Export Citation
  • 3.

    ParsonsADaleyABeghRAveyardP. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ2010;340:b5569.

    • Search Google Scholar
    • Export Citation
  • 4.

    BalduyckBSardariNPCogenA. The effect of smoking cessation on quality of life after lung cancer surgery. Eur J Cardiothorac Surg2011;40:14321437.

    • Search Google Scholar
    • Export Citation
  • 5.

    ChenAMChenLMVaughanA. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys2011;79:414419.

    • Search Google Scholar
    • Export Citation
  • 6.

    GritzERFingeretMCVidrineDJ. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer2006;106:1727.

    • Search Google Scholar
    • Export Citation
  • 7.

    BrowmanGPWongGHodsonI. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med1993;328:159163.

    • Search Google Scholar
    • Export Citation
  • 8.

    DreslerCMGritzER. Smoking, smoking cessation and the oncologist. Lung Cancer2001;34:315323.

  • 9.

    GronkjaerMEliasenMSkov-EttrupLS. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg2014;259:5271.

    • Search Google Scholar
    • Export Citation
  • 10.

    US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General 2014. Available at: http://www.surgeongeneral.gov/library/reports/50-years-of-progress/. Accessed October 7 2016.

    • Search Google Scholar
    • Export Citation
  • 11.

    SchnollRAJamesCMalstromB. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med2003;25:214221.

    • Search Google Scholar
    • Export Citation
  • 12.

    GritzERNisenbaumRElashoffRHolmesEC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control1991;2:105112.

    • Search Google Scholar
    • Export Citation
  • 13.

    GritzERCarrCRRapkinD. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev1993;2:261270.

    • Search Google Scholar
    • Export Citation
  • 14.

    ValentineAD. Depression, anxiety, and delirium. In: PazdurRCoiaLHoskinsWJWagmanL eds. Cancer Management: A Multidisciplinary Approach10th ed.New York, NY: The Oncology Group; 2007:855899.

    • Search Google Scholar
    • Export Citation
  • 15.

    Gustavsson-LilliusMJulkunenJKeskivaaraPHietanenP. Sense of coherence and distress in cancer patients and their partners. Psychooncology2007;16:11001110.

    • Search Google Scholar
    • Export Citation
  • 16.

    StarkDHouseA. Anxiety in cancer patients. Br J Cancer2000;83:12611267.

  • 17.

    Karam-HageMCinciripiniPMGritzER. Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin2014;64:272290.

    • Search Google Scholar
    • Export Citation
  • 18.

    MeertAMayerCMilaniM. Smoking cessation interventions among cancer patients. Bull Cancer2006;4:363369.

  • 19.

    MorganGSchnollRAAlfanoCM. National Cancer Institute conference on treating tobacco dependence at cancer centers. J Oncol Pract2011;7:178182.

    • Search Google Scholar
    • Export Citation
  • 20.

    Tobacco Settlement Information. Texas Department of State Health Services Web site. Available at: http://www.dshs.state.tx.us/tobacco/settlement.shtm. Accessed August 1 2016.

    • Search Google Scholar
    • Export Citation
  • 21.

    2008 PHS Guideline Update Panel Liaisons and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care2008;53:12171222.

    • Search Google Scholar
    • Export Citation
  • 22.

    RabiusVKaram-HageMBlalockJACinciripiniPM. Meaningful use “provides a meaningful opportunity”. Cancer2013;20:464468.

  • 23.

    SobellLCSobellMB. Timeline follow-back. In: LittenRZAllenJP eds. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Clifton, NJ: Humana Press; 1992:4172.

    • Search Google Scholar
    • Export Citation
  • 24.

    HeathertonTFKozlowskiLTFreckerRCFagerströmKO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict1991;86:11191127.

    • Search Google Scholar
    • Export Citation
  • 25.

    SaundersJBAaslandOGBaborTF. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II. Addiction1993;88:791804.

    • Search Google Scholar
    • Export Citation
  • 26.

    RadloffLS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas1977;1:385401.

  • 27.

    WatsonDClarkLATellegenA. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol1988;54:10631070.

    • Search Google Scholar
    • Export Citation
  • 28.

    WelschSKSmithSSWetterDW. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol1999;7:354361.

    • Search Google Scholar
    • Export Citation
  • 29.

    SpitzerRLKroenkeKWilliamsJB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA1999;282:17371744.

    • Search Google Scholar
    • Export Citation
  • 30.

    SteadLFLancaserT. Does a combination of smoking cessation medication and behavioural support help smokers to stop? Available at: http://summaries.cochrane.org/CD008286/does-a-combination-of-smoking-cessation-medication-and-behavioural-support-help-smokers-to-stop. Accessed August 27 2016.

    • Search Google Scholar
    • Export Citation
  • 31.

    MillsEJWuPLockhartI. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. Ann Med2012;44:588597.

    • Search Google Scholar
    • Export Citation
  • 32.

    OnckenCAriasAJFeinnR. Topiramate for smoking cessation: a randomized, placebo-controlled pilot study. Nicotine Tob Res2014;16:288296.

    • Search Google Scholar
    • Export Citation
  • 33.

    JainRJhanjeeSJainV. A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India. Nicotine Tob Res2014;16:5057.

    • Search Google Scholar
    • Export Citation
  • 34.

    EbbertJOFagerstromK. Pharmacological interventions for the treatment of smokeless tobacco use. CNS Drugs2012;26:110.

  • 35.

    AggarwalAJainMJilohaRC. Varenicline for smokeless tobacco dependence. J Postgrad Med2010;56:50.

  • 36.

    GonzalesDHRennardSINidesM. A pooled-analysis of varenicline, an alpha 4 beta 2 nicotinic receptor partial agonist vs bupropion, and placebo for smoking cessation. JAMA2006;296:4755.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 71 71 7
PDF Downloads 37 37 7
EPUB Downloads 0 0 0